APB-A2

N/A

Report date: 2022/04/24 15:40:48

Base Information

Drug NameAPB-A2
Drug Alias NameAPB-A2
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAnti-5'-nucleotidase
Targets5'-nucleotidase
Therapy Area/IndicationsProstatic NeoplasmsPancreatic NeoplasmsCarcinoma, Renal Cell +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAprilBio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAprilBio Co Ltd
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsPancreatic NeoplasmsCarcinoma, Renal Cell +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A